Sponsor:
iRxReminder
Code:
NCT06011408
Conditions
Tardive Dyskinesia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
TDtect
Brief summary:
Conditions
Tardive Dyskinesia
Study ID
NCT06011408
Start date
May 30, 2023
Status verified date
Mar, 2024
Completion date
Dec 31, 2024
Anticipated
Primary completion date
Nov 30, 2024
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
300 participants
Anticipated
Allocation
Non randomized
Intervention Model
Parallel Assignment
Primary purpose
Screening
Arms
other: Taking antipsychotic medication with Tardive Dyskinesia
other: Taking antipsychotic medication without Tardive Dyskinesia
Interventions
TDtect
Primary outcome measure
Central contacts
Locations
Fermata Helath
Recruiting
Brooklyn, New York, United States, 10038
Contacts
Principal Investigator:
Owen Muir, M.D.
Charak Research Center
Recruiting
Garfield Heights, Ohio, United States, 44125
Contacts
Principal Investigator:
Rakesh Ranjan, M.D.
Sponsor
iRxReminder
Last update posted
Mar 12, 2024
Last verified
Mar, 2024
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by iRxReminder on 2024-03-12.